PacBio Cuts HiFi Genome Costs Below $300 with SPRQ-Nx Chemistry Launch
Event summary
- PacBio's SPRQ-Nx sequencing chemistry and multi-use SMRT Cells are now shipping globally, reducing per-genome costs to $345 (sub-$300 at scale).
- AI-powered DeepConsensus algorithm, developed with Google, delivers measurable gains in accuracy and processing speed.
- Beta testing across 20 sites and 1,400 runs showed increased yield and lower failure rates across diverse sample types.
- SPRQ-Nx chemistry and platform improvements will be extended to the Vega benchtop system later in 2026.
The big picture
PacBio's SPRQ-Nx launch addresses a critical cost barrier in high-accuracy genomics, positioning HiFi sequencing for broader adoption in population-scale studies and AI-driven research. The integration of AI across workflows reflects a broader industry trend toward data-rich, automated genomic analysis. With global shipping now underway, PacBio aims to solidify its lead in long-read sequencing as demand for richer genomic datasets grows.
What we're watching
- AI Integration
- How PacBio's collaboration with Google on DeepConsensus will affect sequencing accuracy and adoption rates.
- Cost Scaling
- Whether PacBio can sustain sub-$300 genome costs at scale and maintain profitability.
- Market Expansion
- The pace at which SPRQ-Nx adoption will accelerate population-scale genomics and large cohort studies.
Related topics